Guest Post by Mark Crispin Miller
So she’s the perfect choice to manage NIH—a WOMAN, comfortably in Pfizer’s pocket, and, as head of the National Cancer Institute, all for cancer patients getting jabbed-and-boosted.
Monica Bertagnolli receives applause after being recognized as the next director of the National Cancer Institute in August 2022 [in which post she’s done an aces job, since cancer rates are higher than they’ve ever been, and “experts” like Dr. Bertagnolli are completely “baffled” as to why—MCM].
Having overseen the government’s expenditure of billions on “cancer treatments” often likelier to cause more cancer than to cure it (“Cancer Moonshot” is the perfect name of such a program)—and having vigorously pushed for cancer patients to get “vaccinated,” and then serially boosted—Dr. Bertagnolli has exactly what it takes to keep those NIH trains rolling to the end—MCM.
